X
+ Watchlist
Vascular Biogenics Ltd
0VB:GR
Stuttgart
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding (m)
26.902
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care % Price Change
-0.06%
% Price Change
+0.10%
Related Videos
There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Vascular Biogenics Ltd. is a clinical stage biotechnology company engaged in the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases.
- Dror Harats CEO/Founder
- Amos Ron Chief Financial Officer
- Erez Feige VP:Business Operations
- Yael Cohen VP:Clinical Development
- Naamit Sher VP:Dev & Regulatory
Show More